KLP Kapitalforvaltning AS Has $4.70 Million Stock Position in Solventum Corporation $SOLV

Key Points

• KLP Kapitalforvaltning AS increased its holdings in Solventum Corporation by 20.2% during the second quarter, bringing its total shares to 61,965 with a value of approximately $4.70 million.
• Several analysts have raised their price targets for Solventum, with Wells Fargo increasing it from $79.00 to $82.00 and Argus issuing a buy rating with a target of $90.00.
• Solventum reported an EPS of $1.69 for the last quarter, beating estimates, and has set guidance for FY 2025 at 5.800-5.950 EPS.

KLP Kapitalforvaltning AS grew its position in Solventum Corporation (NYSE:SOLV - Free Report) by 20.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 61,965 shares of the company's stock after buying an additional 10,400 shares during the quarter. KLP Kapitalforvaltning AS's holdings in Solventum were worth $4,699,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Chelsea Counsel Co. boosted its holdings in shares of Solventum by 720.7% in the second quarter. Chelsea Counsel Co. now owns 10,595 shares of the company's stock worth $804,000 after buying an additional 9,304 shares during the period. ST Germain D J Co. Inc. boosted its holdings in shares of Solventum by 84.6% during the second quarter. ST Germain D J Co. Inc. now owns 825 shares of the company's stock worth $63,000 after purchasing an additional 378 shares during the period. CX Institutional boosted its holdings in shares of Solventum by 11.7% during the second quarter. CX Institutional now owns 2,376 shares of the company's stock worth $180,000 after purchasing an additional 249 shares during the period. ORG Wealth Partners LLC acquired a new stake in shares of Solventum during the second quarter worth approximately $71,000. Finally, Public Employees Retirement System of Ohio boosted its holdings in shares of Solventum by 0.9% during the second quarter. Public Employees Retirement System of Ohio now owns 63,719 shares of the company's stock worth $4,832,000 after purchasing an additional 583 shares during the period.

Analyst Ratings Changes

Several analysts recently commented on SOLV shares. Wells Fargo & Company raised their price target on shares of Solventum from $79.00 to $82.00 and gave the stock an "equal weight" rating in a report on Monday, September 15th. Argus upgraded shares of Solventum from a "hold" rating to a "buy" rating and set a $90.00 price target for the company in a report on Tuesday, July 1st. UBS Group started coverage on shares of Solventum in a report on Wednesday, October 1st. They set a "neutral" rating and a $77.00 price target for the company. Zacks Research upgraded shares of Solventum from a "hold" rating to a "strong-buy" rating in a report on Monday, September 15th. Finally, Jefferies Financial Group initiated coverage on shares of Solventum in a report on Thursday, September 11th. They set a "hold" rating and a $80.00 price target for the company. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $84.89.

Solventum Price Performance

NYSE SOLV opened at $70.53 on Friday. The company has a quick ratio of 0.86, a current ratio of 1.22 and a debt-to-equity ratio of 2.14. The stock has a market capitalization of $12.23 billion, a PE ratio of 32.65, a price-to-earnings-growth ratio of 2.92 and a beta of 0.50. The company has a 50 day moving average price of $72.75 and a two-hundred day moving average price of $72.11. Solventum Corporation has a 12-month low of $60.70 and a 12-month high of $85.92.

Solventum (NYSE:SOLV - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $1.69 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.45 by $0.24. The firm had revenue of $2.16 billion during the quarter, compared to analysts' expectations of $2.12 billion. Solventum had a net margin of 4.52% and a return on equity of 29.93%. The company's revenue was up 3.8% compared to the same quarter last year. During the same period in the previous year, the company earned $1.56 earnings per share. Solventum has set its FY 2025 guidance at 5.800-5.950 EPS. As a group, equities analysts predict that Solventum Corporation will post 6.58 earnings per share for the current fiscal year.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.